{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:32:58Z","timestamp":1777681978222,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.gofs.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T16:08:01Z","timestamp":1522858081000},"page":"414-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dispositif intra-ut\u00e9rin et infections g\u00e9nitales hautes\u00a0: mythe ou r\u00e9alit\u00e9\u00a0?"],"prefix":"10.1016","volume":"46","author":[{"given":"T.","family":"Straub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Yaron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2018.03.002_bib0165","unstructured":"U.S. Selected practice recommendations for contraceptive use. 2016 [cit\u00e9 24 mai 2016]."},{"issue":"5","key":"10.1016\/j.gofs.2018.03.002_bib0170","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/AOG.0b013e31828ac03a","article-title":"Pitfalls of research linking the intrauterine device to pelvic inflammatory disease","volume":"121","author":"Hubacher","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.03.002_bib0175","first-page":"339","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.gofs.2018.03.002_bib0180","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.contraception.2015.06.008","article-title":"Intrauterine device use in an urban university clinic: safety of use in a population at high risk for sexually transmitted infections","volume":"92","author":"Drake","year":"2015","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.03.002_bib0185","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.contraception.2006.12.017","article-title":"Intrauterine devices upper and lower genital tract infections","volume":"75","author":"Meirik","year":"2007","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gofs.2018.03.002_bib0190","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1089\/jwh.2015.5190","article-title":"Positive testing for Neisseria gonorrhoeae and Chlamydia trachomatis and the risk of pelvic inflammatory disease in IUD users","volume":"24","author":"Birgisson","year":"2015","journal-title":"J Womens Health"},{"key":"10.1016\/j.gofs.2018.03.002_bib0195","doi-asserted-by":"crossref","unstructured":"Mohllajee AP, Curtis KM, Peterson HB. Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review. Contraception; 2006: 73(2); 145\u201353.","DOI":"10.1016\/j.contraception.2005.08.007"},{"key":"10.1016\/j.gofs.2018.03.002_bib0200","doi-asserted-by":"crossref","unstructured":"Stanback J, Shelton JD. Pelvic inflammatory disease attributable to the IUD: modeling risk in West Africa. Contraception; 2008: 77(4); 227\u20139.","DOI":"10.1016\/j.contraception.2008.01.001"},{"key":"10.1016\/j.gofs.2018.03.002_bib0205","doi-asserted-by":"crossref","unstructured":"Shelton JD. Risk of clinical pelvic inflammatory disease attributable to an intrauterine device. Lancet; 2001: 357(9254); 443.","DOI":"10.1016\/S0140-6736(00)04012-5"},{"issue":"23","key":"10.1016\/j.gofs.2018.03.002_bib0210","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0968-8080(04)23123-8","article-title":"Intrauterine contraceptive devices and risk of pelvic inflammatory disease: standard of care in high STI prevalence settings","volume":"12","author":"Steen","year":"2004","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.gofs.2018.03.002_bib0215","unstructured":"WHO. Selected practice recommendations for contraceptive use. 2016 [cit\u00e9 24 mai 2016]."},{"key":"10.1016\/j.gofs.2018.03.002_bib0220","doi-asserted-by":"crossref","unstructured":"Sivin I. Utility and drawbacks of continuous use of a copper T IUD for 20 years. Contraception; 2007: 75(6); S70\u20135.","DOI":"10.1016\/j.contraception.2007.01.016"},{"issue":"6","key":"10.1016\/j.gofs.2018.03.002_bib0225","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/00016340902893678","article-title":"Prolonged use of intrauterine contraceptive device as a risk factor for tubo-ovarian abscess","volume":"88","author":"Charonis","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"12","key":"10.1016\/j.gofs.2018.03.002_bib0230","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/j.0001-6349.2005.00810.x","article-title":"\u2018Older\u2019 age is a risk factor for pelvic inflammatory disease in intrauterine device users","volume":"84","author":"Viberga","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"10.1016\/j.gofs.2018.03.002_bib0235","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1155\/2005\/376830","article-title":"Microbiology profile in women with pelvic inflammatory disease in relation to IUD use","volume":"13","author":"Viberga","year":"2005","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.gofs.2018.03.002_bib0240","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1099\/jmm.0.46197-0","article-title":"Biofilm formation on intrauterine devices in relation to duration of use","volume":"54","author":"P\u00e1l","year":"2005","journal-title":"J Med Microbiol"},{"issue":"2","key":"10.1016\/j.gofs.2018.03.002_bib0245","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000381772","article-title":"Predictive markers of tubo-ovarian abscess in pelvic inflammatory disease","volume":"81","author":"Lee","year":"2016","journal-title":"Gynecol Obstet Invest"},{"issue":"2","key":"10.1016\/j.gofs.2018.03.002_bib0250","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000088751","article-title":"The impact of age and intrauterine contraception on the clinical course of pelvic inflammatory disease","volume":"61","author":"Viberga","year":"2006","journal-title":"Gynecol Obstet Invest"},{"issue":"4","key":"10.1016\/j.gofs.2018.03.002_bib0255","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000072076","article-title":"Tubo-ovarian abscess in older women: is the woman's age a risk factor for failed response to conservative treatment?","volume":"55","author":"Halperin","year":"2003","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.gofs.2018.03.002_bib0260","doi-asserted-by":"crossref","unstructured":"R. Lyus, P. Lohr, S.Prager, Board of the Society of Family Planning. Use of the Mirena\u2122 LNG-IUS and Paragard\u2122 CuT380A intrauterine devices in nulliparous women. Contraception; 2010: 81(5); 367\u201371.","DOI":"10.1016\/j.contraception.2010.01.010"},{"key":"10.1016\/j.gofs.2018.03.002_bib0265","doi-asserted-by":"crossref","unstructured":"Steenland MW, Zapata LB, Brahmi D, Marchbanks PA, Curtis KM. Appropriate follow-up to detect potential adverse events after initiation of select contraceptive methods: a systematic review. Contraception; 2013: 87(5); 611\u201324.","DOI":"10.1016\/j.contraception.2012.09.017"},{"issue":"3","key":"10.1016\/j.gofs.2018.03.002_bib0270","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/13814780409044540","article-title":"Complications of the intrauterine device in nulliparous and parous women","volume":"10","author":"Veldhuis","year":"2004","journal-title":"Eur J Gen Pract"},{"key":"10.1016\/j.gofs.2018.03.002_bib0275","doi-asserted-by":"crossref","unstructured":"Prager S, Darney PD. The levonorgestrel intrauterine system in nulliparous women. Contraception; 2007: 75(6); S12\u20135.","DOI":"10.1016\/j.contraception.2007.01.018"},{"key":"10.1016\/j.gofs.2018.03.002_bib0280","doi-asserted-by":"crossref","unstructured":"Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet; 2000: 356(9234): 1013\u20139.","DOI":"10.1016\/S0140-6736(00)02699-4"},{"issue":"2","key":"10.1016\/j.gofs.2018.03.002_bib0285","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/13625180500279789","article-title":"Characteristics of women at low risk of STI presenting with pelvic inflammatory disease","volume":"11","author":"Viberga","year":"2006","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6","key":"10.1016\/j.gofs.2018.03.002_bib0290","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/AOG.0b013e318273364c","article-title":"Neisseria gonorrhea and Chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory disease","volume":"120","author":"Sufrin","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2018.03.002_bib0295","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0010-7824(98)00114-0","article-title":"Characterization of calcified deposits on contraceptive intrauterine devices","volume":"58","author":"Patai","year":"1998","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.gofs.2018.03.002_bib0300","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0301-2115(02)00342-1","article-title":"A randomized controlled trial of coil removal prior to treatment of pelvic inflammatory disease","volume":"107","author":"Altunyurt","year":"2003","journal-title":"Eur J Obstet Gyneco Reprod Biol"},{"issue":"2","key":"10.1016\/j.gofs.2018.03.002_bib0305","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijgo.2015.11.028","article-title":"Updated French guidelines for diagnosis and management of pelvic inflammatory disease","volume":"134","author":"Brun","year":"2016","journal-title":"Int J Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.gofs.2018.03.002_bib0310","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.contraception.2016.10.006","article-title":"The safety of intrauterine devices among young women: a systematic review","volume":"95","author":"Jatlaoui","year":"2017","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.gofs.2018.03.002_bib0315","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.contraception.2013.10.003","article-title":"IUD use in France: women's and physician's perspectives","volume":"89","author":"Moreau","year":"2014","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gofs.2018.03.002_bib0160","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJMcp1608736","article-title":"Long-acting reversible contraception","volume":"376","author":"Curtis","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918300795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918300795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T03:35:58Z","timestamp":1571024158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718918300795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S2468718918300795"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2018.03.002","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dispositif intra-ut\u00e9rin et infections g\u00e9nitales hautes\u00a0: mythe ou r\u00e9alit\u00e9\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}